Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (29)
Abiza Wali, Mashooq Ahmad Dar, Aarif Ali, Iyman Rasool, Lubna Tariq, Azher Arafah, Muneeb U. Rehman, Bashir Ahmad Malla & Adil Farooq Wali. 2023. Pharmacogenomics. Pharmacogenomics
169
194
.
Huihui Du, Jingsong Ma, Wei Zhou, Mo Li, Cong Huai, Lu Shen, Hao Wu, Xianglong Zhao, Na Zhang, Songyin Gao, Qi Wang, Lin He, Xuming Wu, Shengying Qin & Mingzhe Zhao. (2022) Methylome-wide association study of different responses to risperidone in schizophrenia. Frontiers in Pharmacology 13.
Crossref
Crossref
Atul Kabra, Ruchika Garg, James Brimson, Jelena Živković, Saud Almawash, Muhammad Ayaz, Asif Nawaz, Syed Shams Ul Hassan & Simona Bungau. (2022) Mechanistic insights into the role of plant polyphenols and their nano-formulations in the management of depression. Frontiers in Pharmacology 13.
Crossref
Crossref
Yurong Sun, Xinyi Wang, Shui Tian, Zhilu Chen, Huan Wang, Li Xue, Rui Yan, Zhijian Yao & Qing Lu. (2021)
An Investigation into the Association Between Dopamine Receptor
D1
Multilocus Genetic Variation, Multiparametric Magnetic Resonance Imaging, and Antidepressant Treatment
. Journal of Magnetic Resonance Imaging 56:1, pages 282-290.
Crossref
Crossref
Falk W. Lohoff. (2022) Targeting Unmet Clinical Needs in the Treatment of Alcohol Use Disorder. Frontiers in Psychiatry 13.
Crossref
Crossref
Mrinalini Bhagawati & Sudip Paul. (2021) Machine Learning for Major Depressive Disorder: An Overview. Machine Learning for Major Depressive Disorder: An Overview.
Elena Sergeevna Ilyina, Natal’a Valer’evna Filippova & Yulia Borisovna Barylnik. (2021) Pharmacogenetics of antidepressants (from history to the present). Vestnik nevrologii, psihiatrii i nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery):9, pages 713-729.
Crossref
Crossref
Baoyu Yuan, Xiaoyan Sun, Zhi Xu, Mengjia Pu, Yonggui Yuan & Zhijun Zhang. (2020) Influence of genetic polymorphisms in homocysteine and lipid metabolism systems on antidepressant drug response. BMC Psychiatry 20:1.
Crossref
Crossref
Tian Shen, Xingyu Li, Lei Chen, Zimu Chen, Tingting Tan, Tiantian Hua, Bingwei Chen, Yonggui Yuan, Zhijun Zhang, Liz Kuney & Zhi Xu. (2020) The relationship of tryptophan hydroxylase-2 methylation to early-life stress and its impact on short-term antidepressant treatment response. Journal of Affective Disorders 276, pages 850-858.
Crossref
Crossref
Olga S. Toropova, Alevtina F. Brovkina & Dmitry A. Sychev. (2020) Endocrine ophthalmopathy: pharmacogenetic markers of efficiency of glucocorticoid therapy. Annals of the Russian academy of medical sciences 75:3, pages 250-255.
Crossref
Crossref
Mei Han & Chao Deng. (2020) BDNF as a pharmacogenetic target for antipsychotic treatment of schizophrenia. Neuroscience Letters 726, pages 133870.
Crossref
Crossref
Kevin Sean O’Connell, Nathaniel Wade McGregor, Robin Emsley, Soraya Seedat & Louise Warnich. (2019) The Potential Role of Regulatory Genes (DNMT3A, HDAC5, and HDAC9) in Antipsychotic Treatment Response in South African Schizophrenia Patients. Frontiers in Genetics 10.
Crossref
Crossref
Ellen S. Ovenden, Nathaniel W. McGregor, Robin A. Emsley & Louise Warnich. (2018) DNA methylation and antipsychotic treatment mechanisms in schizophrenia: Progress and future directions. Progress in Neuro-Psychopharmacology and Biological Psychiatry 81, pages 38-49.
Crossref
Crossref
Zhi Xu, Gavin P. Reynolds, Yonggui Yuan, Yanyan Shi, Mengjia Pu & Zhijun Zhang. (2016) TPH-2 Polymorphisms Interact with Early Life Stress to Influence Response to Treatment with Antidepressant Drugs. International Journal of Neuropsychopharmacology 19:11, pages pyw070.
Crossref
Crossref
Maya Amitai, Sefi Kronenberg, Miri Carmel, Elena Michaelovsky, Amos Frisch, David Brent, Alan Apter, Alon Chen, Abraham Weizman & Silvana Fennig. (2016) Pharmacogenetics of citalopram-related side effects in children with depression and/or anxiety disorders. Journal of Neural Transmission 123:11, pages 1347-1354.
Crossref
Crossref
Shareefa DalvieNastassja KoenNathaniel McGregorKevin O'ConnellLouise WarnichRaj RamesarCaroline M. NievergeltDan J. Stein. (2016) Toward a Global Roadmap for Precision Medicine in Psychiatry: Challenges and Opportunities. OMICS: A Journal of Integrative Biology 20:10, pages 557-564.
Crossref
Crossref
Laura Pina-Camacho, Covadonga M. Díaz-Caneja, Pilar A. Saiz, Julio Bobes, Iluminada Corripio, Eva Grasa, Roberto Rodriguez-Jimenez, Miryam Fernández, Julio Sanjuán, Aurelio García-López, Cecilia Tapia-Casellas, María Álvarez-Blázquez, David Fraguas, Marina Mitjans, Bárbara Arias & Celso Arango. (2014) Pharmacogenetic study of second-generation antipsychotic long-term treatment metabolic side effects (the SLiM Study): Rationale, objectives, design and sample description. Revista de Psiquiatría y Salud Mental (English Edition) 7:4, pages 166-178.
Crossref
Crossref
Laura Pina-Camacho, Covadonga M. Díaz-Caneja, Pilar A. Saiz, Julio Bobes, Iluminada Corripio, Eva Grasa, Roberto Rodriguez-Jimenez, Miryam Fernández, Julio Sanjuán, Aurelio García-López, Cecilia Tapia-Casellas, María Álvarez-Blázquez, David Fraguas, Marina Mitjans, Bárbara Arias & Celso Arango. (2014) Estudio farmacogenético del tratamiento a largo plazo con antipsicóticos de segunda generación y sus efectos adversos metabólicos (Estudio SLiM): justificación, objetivos, diseño y descripción de la muestra. Revista de Psiquiatría y Salud Mental 7:4, pages 166-178.
Crossref
Crossref
Britt I. Drögemöller, Galen E.B. Wright, Dana J.H. Niehaus, Robin Emsley & Louise Warnich. (2013) Next-generation sequencing of pharmacogenes. Pharmacogenetics and Genomics 23:12, pages 666-674.
Crossref
Crossref
Neelroop N. Parikshak & Daniel H. Geschwind. 2013. Genomic and Personalized Medicine. Genomic and Personalized Medicine
1018
1027
.
Sergi Mas, Adrián LLerena, Jerónimo Saíz, Miquel Bernardo & Amalia Lafuente. (2012) Strengths and weaknesses of pharmacogenetic studies of antipsychotic drugs: the potential value of the PEPs study. Pharmacogenomics 13:15, pages 1773-1782.
Crossref
Crossref
Sneha Narasimhan, Tiffany D. Aquino, Pushpinder K. Multani, Karl Rickels & Falk W. Lohoff. (2012) Variation in the catechol-O-methyltransferase (COMT) gene and treatment response to venlafaxine XR in generalized anxiety disorder. Psychiatry Research 198:1, pages 112-115.
Crossref
Crossref
Zhi Xu, Zhijun Zhang, Yanyan Shi, Mengjia Pu, Yonggui Yuan, Xiangrong Zhang, Lingjiang Li & Gavin P Reynolds. (2011) Influence and interaction of genetic polymorphisms in the serotonin system and life stress on antidepressant drug response. Journal of Psychopharmacology 26:3, pages 349-359.
Crossref
Crossref
Min-Soo Lee. (2011) Pharmacogenetics in the treatment of depression in Asia. Asia-Pacific Psychiatry 3:3, pages 107-108.
Crossref
Crossref
Zhi Xu, Zhijun Zhang, Yanyan Shi, Mengjia Pu, Yonggui Yuan, Xiangrong Zhang & Lingjiang Li. (2011) Influence and interaction of genetic polymorphisms in catecholamine neurotransmitter systems and early life stress on antidepressant drug response. Journal of Affective Disorders 133:1-2, pages 165-173.
Crossref
Crossref
. (2011) Current World Literature. Current Opinion in Psychiatry 24:1, pages 78-87.
Crossref
Crossref
Charles DeBattista, Gustavo Kinrys, Daniel Hoffman, Corey Goldstein, John Zajecka, James Kocsis, Martin Teicher, Steven Potkin, Adrian Preda, Gurmeet Multani, Len Brandt, Mark Schiller, Dan Iosifescu & Maurizio Fava. (2011) The use of referenced-EEG (rEEG) in assisting medication selection for the treatment of depression. Journal of Psychiatric Research 45:1, pages 64-75.
Crossref
Crossref
Falk W. Lohoff. (2010) Overview of the Genetics of Major Depressive Disorder. Current Psychiatry Reports 12:6, pages 539-546.
Crossref
Crossref
Tatjana Pekmezović. (2010) Gene-Environment Interaction: A Genetic-Epidemiological Approach. Journal of Medical Biochemistry 29:3, pages 131-134.
Crossref
Crossref